These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 22086553)
21. BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration. Garceau D; Chauret N Pulm Pharmacol Ther; 2019 Jun; 56():56-62. PubMed ID: 30902655 [TBL] [Abstract][Full Text] [Related]
22. Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating. Sivcev S; Slavikova B; Ivetic M; Knezu M; Kudova E; Zemkova H J Steroid Biochem Mol Biol; 2020 Sep; 202():105725. PubMed ID: 32652201 [TBL] [Abstract][Full Text] [Related]
23. Antinociceptive properties of a non-nucleotide P2X3/P2X2/3 receptor antagonist. McGaraughty S; Jarvis MF Drug News Perspect; 2005 Oct; 18(8):501-7. PubMed ID: 16391720 [TBL] [Abstract][Full Text] [Related]
24. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels. Lewis CJ; Evans RJ Br J Pharmacol; 2000 Dec; 131(8):1659-66. PubMed ID: 11139444 [TBL] [Abstract][Full Text] [Related]
25. Medicinal chemistry of P2X receptors: allosteric modulators. Müller CE Curr Med Chem; 2015; 22(7):929-41. PubMed ID: 25524251 [TBL] [Abstract][Full Text] [Related]
36. Regulatory interdependence of cloned epithelial Na+ channels and P2X receptors. Wildman SS; Marks J; Churchill LJ; Peppiatt CM; Chraibi A; Shirley DG; Horisberger JD; King BF; Unwin RJ J Am Soc Nephrol; 2005 Sep; 16(9):2586-97. PubMed ID: 16000699 [TBL] [Abstract][Full Text] [Related]
37. [3H]A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2/3 and P2X3 receptors. Jarvis MF; Bianchi B; Uchic JT; Cartmell J; Lee CH; Williams M; Faltynek C J Pharmacol Exp Ther; 2004 Jul; 310(1):407-16. PubMed ID: 15024037 [TBL] [Abstract][Full Text] [Related]
38. P2X1 and P2X2 receptors in the central nervous system as possible drug targets. Hausmann R; Schmalzing G CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):675-86. PubMed ID: 22963438 [TBL] [Abstract][Full Text] [Related]
39. Agonists and Antagonists for Purinergic Receptors. Müller CE; Baqi Y; Namasivayam V Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479 [TBL] [Abstract][Full Text] [Related]
40. Medicinal chemistry of adenosine, P2Y and P2X receptors. Jacobson KA; Müller CE Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]